메뉴 건너뛰기




Volumn 297, Issue 1-2, 2005, Pages 110-119

Development and application of high throughput plasma stability assay for drug discovery

Author keywords

Enzymes; High throughput; HPLC; Hydrolysis; LC MS; Plasma stability; Prodrugs; Stability

Indexed keywords

ALBENDAZOLE; ANTITUSSIVE AGENT; BENFLUOREX; BUFFER; DILTIAZEM; DIMETHOXANATE; DIMETHYL SULFOXIDE; PIPEROCAINE; POLDINE METHYLSULFATE; PROPANTHELINE BROMIDE; UNCLASSIFIED DRUG; VINPOCETINE;

EID: 19344364710     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.03.022     Document Type: Article
Times cited : (165)

References (26)
  • 1
    • 10744223326 scopus 로고    scopus 로고
    • Design and synthesis of pyrrolidine-5,5′-trans-lactams (5-oxo-hexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 4. Antiviral activity and plasma stability
    • A.D. Borthwick, D.E. Davies, P.F. Ertl, A.M. Exall, T.M. Haley, G.J. Hart, D.L. Jackson, N.R. Parry, A. Patikis, N. Trivedi, G.G. Weingarten, and J.M. Woolven Design and synthesis of pyrrolidine-5,5′-trans-lactams (5-oxo-hexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 4. Antiviral activity and plasma stability J. Med. Chem. 46 2003 4428 4449
    • (2003) J. Med. Chem. , vol.46 , pp. 4428-4449
    • Borthwick, A.D.1    Davies, D.E.2    Ertl, P.F.3    Exall, A.M.4    Haley, T.M.5    Hart, G.J.6    Jackson, D.L.7    Parry, N.R.8    Patikis, A.9    Trivedi, N.10    Weingarten, G.G.11    Woolven, J.M.12
  • 2
    • 0037042763 scopus 로고    scopus 로고
    • Pyrrolidine-5,5-trans-lactams as novel mechanism-based inhibitors of human cytomegalovirus protease. Part 3: Potency and plasma stability
    • A.D. Borthwick, A.M. Exall, T.M. Haley, D.L. Jackson, A.M. Mason, and G.G. Weingarten Pyrrolidine-5,5-trans-lactams as novel mechanism-based inhibitors of human cytomegalovirus protease. Part 3: potency and plasma stability Bioorg. Med. Chem. Lett. 12 2002 1719 1722
    • (2002) Bioorg. Med. Chem. Lett. , vol.12 , pp. 1719-1722
    • Borthwick, A.D.1    Exall, A.M.2    Haley, T.M.3    Jackson, D.L.4    Mason, A.M.5    Weingarten, G.G.6
  • 4
    • 0345490845 scopus 로고    scopus 로고
    • Effect of methanol, ethanol, dimethyl sulfoxide, and acetonitrile on in vitro activities of cDNA-expressed human cytochromes P-450
    • W.F. Busby Jr., J.M. Ackermann, and C.L. Crespi Effect of methanol, ethanol, dimethyl sulfoxide, and acetonitrile on in vitro activities of cDNA-expressed human cytochromes P-450 Drug. Metab. Dispos. 27 1999 246 249
    • (1999) Drug. Metab. Dispos. , vol.27 , pp. 246-249
    • Busby Jr., W.F.1    Ackermann, J.M.2    Crespi, C.L.3
  • 5
    • 0031940804 scopus 로고    scopus 로고
    • Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes
    • N. Chauret, A. Gauthier, and D.A. Nicoll-Griffith Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes Drug. Metab. Dispos. 26 1998 1 4
    • (1998) Drug. Metab. Dispos. , vol.26 , pp. 1-4
    • Chauret, N.1    Gauthier, A.2    Nicoll-Griffith, D.A.3
  • 6
    • 0037523454 scopus 로고    scopus 로고
    • Profiling drug-like properties in discovery research
    • L. Di, and E.H. Kerns Profiling drug-like properties in discovery research Curr. Opin. Chem. Biol. 7 2003 402 408
    • (2003) Curr. Opin. Chem. Biol. , vol.7 , pp. 402-408
    • Di, L.1    Kerns, E.H.2
  • 7
    • 2142722247 scopus 로고    scopus 로고
    • Optimization of a higher throughput microsomal stability screening assay for profiling drug discovery candidates
    • L. Di, E.H. Kerns, H. Yan, T.A. Kleintop, O.J. McConnell, and D.M. Huryn Optimization of a higher throughput microsomal stability screening assay for profiling drug discovery candidates J. Biomol. Screen. 8 2003 453 462
    • (2003) J. Biomol. Screen. , vol.8 , pp. 453-462
    • Di, L.1    Kerns, E.H.2    Yan, H.3    Kleintop, T.A.4    McConnell, O.J.5    Huryn, D.M.6
  • 8
    • 2642513322 scopus 로고    scopus 로고
    • Experimental design on single time point high-throughput microsomal stability assay
    • L. Di, E.H. Kerns, N. Gao, S. Li, Y. Huang, J.L. Bourassa, and D.M. Huryn Experimental design on single time point high-throughput microsomal stability assay J. Pharm. Sci. 93 2004 1537 1544
    • (2004) J. Pharm. Sci. , vol.93 , pp. 1537-1544
    • Di, L.1    Kerns, E.H.2    Gao, N.3    Li, S.4    Huang, Y.5    Bourassa, J.L.6    Huryn, D.M.7
  • 10
    • 2342481809 scopus 로고    scopus 로고
    • Lessons learned from marketed and investigational prodrugs
    • P. Ettmayer, G.L. Amidon, B. Clement, and B. Testa Lessons learned from marketed and investigational prodrugs J. Med. Chem. 47 2004 2393 2404
    • (2004) J. Med. Chem. , vol.47 , pp. 2393-2404
    • Ettmayer, P.1    Amidon, G.L.2    Clement, B.3    Testa, B.4
  • 11
    • 1642581054 scopus 로고    scopus 로고
    • A new aliphatic amino prodrug system for the delivery of small molecules and proteins utilizing novel PEG derivatives
    • R.B. Greenwald, H. Zhao, K. Yang, P. Reddy, and A. Martinez A new aliphatic amino prodrug system for the delivery of small molecules and proteins utilizing novel PEG derivatives J. Med. Chem. 47 2004 726 734
    • (2004) J. Med. Chem. , vol.47 , pp. 726-734
    • Greenwald, R.B.1    Zhao, H.2    Yang, K.3    Reddy, P.4    Martinez, A.5
  • 12
    • 15144359972 scopus 로고    scopus 로고
    • How an increase in the carbon chain length of the ester moiety affects the stability of a homologous series of oxprenolol esters in the presence of biological enzymes
    • C. Geraldine, and M. Jordan How an increase in the carbon chain length of the ester moiety affects the stability of a homologous series of oxprenolol esters in the presence of biological enzymes J. Pharm. Sci. 87 1998 880 885
    • (1998) J. Pharm. Sci. , vol.87 , pp. 880-885
    • Geraldine, C.1    Jordan, M.2
  • 14
    • 0037376928 scopus 로고    scopus 로고
    • Pharmaceutical profiling in drug discovery
    • E.H. Kerns, and L. Di Pharmaceutical profiling in drug discovery Drug Discov. Today 8 2003 316 323
    • (2003) Drug Discov. Today , vol.8 , pp. 316-323
    • Kerns, E.H.1    Di, L.2
  • 15
    • 0035150465 scopus 로고    scopus 로고
    • High throughput physicochemical profiling for drug discovery
    • E.H. Kerns High throughput physicochemical profiling for drug discovery J. Pharm. Sci. 90 2001 1838 1858
    • (2001) J. Pharm. Sci. , vol.90 , pp. 1838-1858
    • Kerns, E.H.1
  • 17
    • 0033049029 scopus 로고    scopus 로고
    • Automation of metabolic stability studies in microsomes, cytosol and plasma using a 215 gilson liquid handler
    • J.M. Linget, and P. du Vignaud Automation of metabolic stability studies in microsomes, cytosol and plasma using a 215 gilson liquid handler J. Pharm. Biomed. Anal. 19 1999 893 901
    • (1999) J. Pharm. Biomed. Anal. , vol.19 , pp. 893-901
    • Linget, J.M.1    Du Vignaud, P.2
  • 18
    • 0032080488 scopus 로고    scopus 로고
    • Liquid chromatographic analysis in mouse, dog and human plasma; Stability, absorption, metabolism and pharmacokinetics of the anti-HIV agent 2-chloro-5-(2-methyl-5,6-dihydro-1, 4-oxathiin-3-yl carboxamido) isopropylbenzoate (NSC 615985, UC84)
    • A.A. Nomeir, M.F. McComish, N.F. Ferrala, D. Silveira, J.M. Covey, and M. Chadwick Liquid chromatographic analysis in mouse, dog and human plasma; stability, absorption, metabolism and pharmacokinetics of the anti-HIV agent 2-chloro-5-(2-methyl-5,6-dihydro-1, 4-oxathiin-3-yl carboxamido) isopropylbenzoate (NSC 615985, UC84) Pharm. Biomed. Anal. 17 1998 27 38
    • (1998) Pharm. Biomed. Anal. , vol.17 , pp. 27-38
    • Nomeir, A.A.1    McComish, M.F.2    Ferrala, N.F.3    Silveira, D.4    Covey, J.M.5    Chadwick, M.6
  • 19
    • 0032968630 scopus 로고    scopus 로고
    • Direct determination of stability of protease inhibitors in plasma by HPLC with automated column-switching
    • S.X. Peng, M.J. Strojnowski, and D.M. Bornes Direct determination of stability of protease inhibitors in plasma by HPLC with automated column-switching J. Pharm. Biomed. Anal. 25 1999 343 349
    • (1999) J. Pharm. Biomed. Anal. , vol.25 , pp. 343-349
    • Peng, S.X.1    Strojnowski, M.J.2    Bornes, D.M.3
  • 23
    • 85081435474 scopus 로고    scopus 로고
    • Personal communication.
    • Stella, V., 2005. Personal communication.
    • (2005)
    • Stella, V.1
  • 24
    • 0032920847 scopus 로고    scopus 로고
    • Synthesis stereoselective enzymatic hydrolysis, and skin permeation of diastereomeric propranolol ester prodrugs
    • C. Udata, G. Tirucherai, and A.K. Mitra Synthesis stereoselective enzymatic hydrolysis, and skin permeation of diastereomeric propranolol ester prodrugs J. Pharm. Sci. 1999 544 550
    • (1999) J. Pharm. Sci. , pp. 544-550
    • Udata, C.1    Tirucherai, G.2    Mitra, A.K.3
  • 25
    • 0037175444 scopus 로고    scopus 로고
    • Semi-automated determination of plasma stability of drug discovery compounds using liquid chromotography-tandem mass spectrometry
    • G. Wang, Y Hsieh, YY. Lau, K.C. Cheng, K. Ng, W.A. Korfmacher, and R.E. White Semi-automated determination of plasma stability of drug discovery compounds using liquid chromotography-tandem mass spectrometry J. Chromatogr. B 780 2002 451 457
    • (2002) J. Chromatogr. B , vol.780 , pp. 451-457
    • Wang, G.1    Hsieh, Y.2    Lau, Y.Y.3    Cheng, K.C.4    Ng, K.5    Korfmacher, W.A.6    White, R.E.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.